• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防产肠毒素大肠杆菌引起的腹泻:志愿者研究所得经验教训

Prevention of diarrhea caused by enterotoxigenic Escherichia coli: lessons learned with volunteers.

作者信息

Graham D Y, Evans D G

机构信息

Department of Medicine, Veterans Administration Medical Center, Houston, Texas 77030.

出版信息

Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S68-72. doi: 10.1093/clinids/12.supplement_1.s68.

DOI:10.1093/clinids/12.supplement_1.s68
PMID:2406859
Abstract

The effectiveness of bismuth subsalicylate in the prevention and treatment of diarrhea induced in volunteers by a single strain of enterotoxigenic Escherichia coli and a standard inoculum size was evaluated. Bismuth subsalicylate (500 mg in a solid dosage form) was administered 8 hours and 2 hours before and 2 hours and 4 hours after the E. coli challenge; treatment was continued four times a day for three additional days. Volunteers experiencing diarrhea were re-randomized to receive placebo or bismuth subsalicylate (300 mg every 30 minutes, for a total of 2.4 g of bismuth subsalicylate, in eight doses). Diarrhea occurred in nine (56%) of the 16 volunteers receiving placebo and in two (13%) of the 15 volunteers receiving bismuth subsalicylate (P less than .03). In vitro studies revealed that bismuth subsalicylate and its components each were bactericidal at concentrations possibly attained during the clinical trial. The effect of the dosage form (solid vs. liquid), the relation of drug administration to meals, and how these variables might greatly influence the effectiveness of bismuth subsalicylate prophylaxis for travelers' diarrhea were considered.

摘要

评估了碱式水杨酸铋对由单一菌株产肠毒素大肠杆菌及标准接种量诱发志愿者腹泻的预防和治疗效果。在大肠杆菌攻击前8小时、2小时以及攻击后2小时、4小时给予碱式水杨酸铋(500毫克固体剂型);治疗持续4次/天,共额外进行3天。出现腹泻的志愿者重新随机分组,接受安慰剂或碱式水杨酸铋(每30分钟300毫克,共2.4克碱式水杨酸铋,分8剂)。16名接受安慰剂的志愿者中有9名(56%)出现腹泻,15名接受碱式水杨酸铋的志愿者中有2名(13%)出现腹泻(P<0.03)。体外研究显示,碱式水杨酸铋及其成分在临床试验可能达到的浓度下均具有杀菌作用。考虑了剂型(固体与液体)、给药与进餐的关系以及这些变量如何可能极大地影响碱式水杨酸铋对旅行者腹泻的预防效果。

相似文献

1
Prevention of diarrhea caused by enterotoxigenic Escherichia coli: lessons learned with volunteers.预防产肠毒素大肠杆菌引起的腹泻:志愿者研究所得经验教训
Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S68-72. doi: 10.1093/clinids/12.supplement_1.s68.
2
Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.次水杨酸铋与安慰剂预防和治疗志愿者肠毒素性大肠杆菌所致腹泻的双盲比较
Gastroenterology. 1983 Nov;85(5):1017-22.
3
Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate.次水杨酸铋片剂预防旅行者腹泻
JAMA. 1987 Mar 13;257(10):1347-50.
4
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth).旅行者腹泻(旅行性肠炎)的预防。(碱式水杨酸铋的预防性给药)
JAMA. 1980 Jan 18;243(3):237-41.
5
Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.系统评价和荟萃分析评估次水杨酸铋预防和治疗感染性腹泻的临床疗效。
Dig Dis Sci. 2021 Jul;66(7):2323-2335. doi: 10.1007/s10620-020-06509-7. Epub 2020 Aug 8.
6
Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.双水杨酸铋对接受口服延迟释放富马酸二甲酯的健康志愿者胃肠道耐受性的影响:PREVENT,一项随机、多中心、双盲、安慰剂对照研究。
Clin Ther. 2018 Dec;40(12):2021-2030.e1. doi: 10.1016/j.clinthera.2018.10.013. Epub 2018 Nov 15.
7
Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea.洛哌丁胺与碱式水杨酸铋治疗急性旅行者腹泻的比较。
JAMA. 1986 Feb 14;255(6):757-60.
8
Use of bismuth subsalicylate for the prevention of travelers' diarrhea.使用碱式水杨酸铋预防旅行者腹泻。
Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S64-7. doi: 10.1093/clinids/12.supplement_1.s64.
9
Prevention of travelers' diarrhea by nonantibiotic drugs.非抗生素药物预防旅行者腹泻
Rev Infect Dis. 1986 May-Jun;8 Suppl 2:S151-9. doi: 10.1093/clinids/8.supplement_2.s151.
10
Drug prophylaxis for travelers' diarrhea.旅行者腹泻的药物预防
Clin Infect Dis. 2002 Mar 1;34(5):628-33. doi: 10.1086/338640. Epub 2002 Jan 16.

引用本文的文献

1
The Controlled Human Infection Model for Enterotoxigenic Escherichia coli.肠产毒性大肠杆菌受控人体感染模型。
Curr Top Microbiol Immunol. 2024;445:189-228. doi: 10.1007/82_2021_242.
2
Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report Series.罗伊氏乳杆菌用于治疗撒丁岛患者幽门螺杆菌感染:病例报告系列
Medicine (Baltimore). 2016 Apr;95(15):e3411. doi: 10.1097/MD.0000000000003411.
3
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.如何有效使用铋剂四联疗法:优点、缺点与问题
Gastroenterol Clin North Am. 2015 Sep;44(3):537-63. doi: 10.1016/j.gtc.2015.05.003. Epub 2015 Jun 19.
4
History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer.幽门螺杆菌、十二指肠溃疡、胃溃疡及胃癌病史。
World J Gastroenterol. 2014 May 14;20(18):5191-204. doi: 10.3748/wjg.v20.i18.5191.